Part of The University of Texas System

You are here

OncLive: Dr. Mesa on recent data with momelotinib in MPNs and myelofibrosis

Time & Date

Monday, July 20, 2020

OncLive: Dr. Mesa on recent data with momelotinib in MPNs and myelofibrosis

Ruben Mesa, MD, director of the Mays Cancer Center, discusses recent data with momelotinib in myelofibrosis. Read and watch the story.

Share this news item